Isospec Analytics has recently secured $1.9M in funding to bring innovative technologies to market that can quickly identify unknown molecules. This advancement is crucial in the development of drugs, nutritional products, and pesticides as accurately identifying molecules is essential for product safety and regulatory approval. Failure to accurately identify molecules can lead to regulatory issues or potential harm to consumers.
The round of funding for Isospec was led by Founderful (formerly Wingman Ventures), with additional support from investors Tiny.vc, another.vc, and Venture Kick. The technology developed by Isospec is able to rapidly identify unknown molecules in just minutes, significantly speeding up the molecular analysis process.
Current methods for identifying unknown molecules rely primarily on mass analysis, which may not always provide enough information for accurate identification. Isospec’s technology generates detailed metrics that make it much easier to definitively identify unknown molecules, improving the accuracy and efficiency of the analysis process.
Isospec’s breakthrough technology originated from the Laboratory of Molecular Physical Chemistry at EPFL and is already being used in industries such as food and agritech for quality control and product research and development. By providing rapid and accurate molecular identification, Isospec’s technology is revolutionizing the way unknown molecules are analyzed and identified, leading to a more efficient drug discovery process and improved product safety standards across various industries.